Cytosorbents
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytosorbents and other ETFs, options, and stocks.About CTSO
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb.
CEOPhillip P. Chan
CEOPhillip P. Chan
Employees149
Employees149
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded1997
Founded1997
Employees149
Employees149
CTSO Key Statistics
Market cap45.93M
Market cap45.93M
Price-Earnings ratio-3.84
Price-Earnings ratio-3.84
Dividend yield—
Dividend yield—
Average volume100.24K
Average volume100.24K
High today$0.7448
High today$0.7448
Low today$0.7102
Low today$0.7102
Open price$0.72
Open price$0.72
Volume148.54K
Volume148.54K
52 Week high$1.61
52 Week high$1.61
52 Week low$0.60
52 Week low$0.60
Stock Snapshot
Cytosorbents(CTSO) stock is priced at $0.73, giving the company a market capitalization of 45.93M. It carries a P/E multiple of -3.84.
As of 2026-01-14, Cytosorbents(CTSO) stock has fluctuated between $0.71 and $0.74. The current price stands at $0.73, placing the stock +2.8% above today's low and -2.0% off the high.
The Cytosorbents(CTSO)'s current trading volume is 148.54K, compared to an average daily volume of 100.24K.
During the past year, Cytosorbents(CTSO) stock moved between $0.60 at its lowest and $1.61 at its peak.
During the past year, Cytosorbents(CTSO) stock moved between $0.60 at its lowest and $1.61 at its peak.
People also own
Based on the portfolios of people who own CTSO. This list is generated using Robinhood data, and it’s not a recommendation.